Acute lymphoblastic leukemia diagnostic study of choice

Acute lymphoblastic leukemia Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Differentiating Acute lymphoblastic leukemia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
Bone X Ray
Echocardiograph and Ultrasound
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Acute lymphoblastic leukemia diagnostic study of choice On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Acute lymphoblastic leukemia diagnostic study of choice All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Acute lymphoblastic leukemia diagnostic study of choice
CDC on Acute lymphoblastic leukemia diagnostic study of choice
Acute lymphoblastic leukemia diagnostic study of choice in the news
Blogs on Acute lymphoblastic leukemia diagnostic study of choice
Directions to Hospitals Treating Acute lymphoblastic leukemia
Risk calculators and risk factors for Acute lymphoblastic leukemia diagnostic study of choice

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Shyam Patel [2]

Overview

The diagnostic study of choice for acute lymphoblastic lymphoma is bone marrow biopsy.

Diagnostic study of choice

The diagnostic study of choice for acute lymphoblastic lymphoma is bone marrow biopsy. A bone marrow biopsy must show 20% or greater blasts of lymphoid immunophenotype. This diagnostic criteria is very similar to that of acute myeloid leukemia.